Skip to Content

Qrons Inc QRON

Morningstar Rating
$0.19 −0.02 (11.68%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

QRON is trading at a 45% discount.
Price
$0.19
Fair Value
$6.14
Uncertainty
Extreme
1-Star Price
$2.36
5-Star Price
$4.35
Economic Moat
Dtcbnt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if QRON is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.21
Day Range
$0.190.19
52-Week Range
$0.170.75
Bid/Ask
$0.15 / $0.28
Market Cap
$2.52 Mil
Volume/Avg
1,000 / 4,669

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Qrons Inc is a biotechnology company developing advanced cell-based solutions to combat neuronal injuries with a laser focus on traumatic brain injuries. The technology would treat a wide range of neurodegenerative diseases. The treatment integrates proprietary, engineered mesenchymal stem cells, 3D printable scaffolding, smart materials, and a novel delivery system. The firm has two product candidates, QS100TM for treating penetrating brain injuries and QS200TM, for treating concussions and other diffused axonal injuries.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
4

Valuation

Metric
QRON
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
QRON
Quick Ratio
0.01
Current Ratio
0.01
Interest Coverage
−6.80
Quick Ratio
QRON

Profitability

Metric
QRON
Return on Assets (Normalized)
−7,204.24%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
QRON
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRZvcppbvnbgQgjd$571.0 Bil
VRTX
Vertex Pharmaceuticals IncSnwhcglWbtpm$107.8 Bil
REGN
Regeneron Pharmaceuticals IncLpkzhnpmDmkmjc$106.1 Bil
MRNA
Moderna IncKwpwqshdNmcpl$42.3 Bil
ARGX
argenx SE ADRGlytbtcrWkys$23.7 Bil
BNTX
BioNTech SE ADRDckqzzvVbm$22.1 Bil
ALNY
Alnylam Pharmaceuticals IncLhsxxhbYlhqcgm$19.4 Bil
BMRN
Biomarin Pharmaceutical IncVmskycwhYwnttx$16.7 Bil
RPRX
Royalty Pharma PLC Class ANsvzvkpjpNvnfhhg$13.6 Bil
INCY
Incyte CorpWvjlrznQrflmlw$12.8 Bil

Sponsor Center